Clinical Trial Update: A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Valerio Therapeutics terminated a Phase 1/2 trial of VIO-01 in patients with advanced or metastatic solid tumors, including breast, ovarian, and prostate cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Prostate Cancer
• Solid Tumors

Drugs mentioned

• VIO-01

Snippet

Sponsor: Valerio Therapeutics | Conditions: Advanced or Metastatic Solid Tumors, Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED